Impaired production of interleukin 6 and tumour necrosis factor alpha in whole blood cell cultures of patients with multiple myeloma.
Cytokine production in whole blood cell cultures can be an indicator of immune cellular status in neoplastic patients. Production of interleukin 6 (IL-6) and tumour necrosis factor alpha (TNF-alpha) after stimulation with lipopolysaccharide was measured in 1/10 diluted whole blood culture of patients with monoclonal gammopathies [monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma (MM)]. With this system, lower production of IL-6 and TNF-alpha at 4, 24 and 48 h in total blood cultures in patients with symptomatic MM was observed. Thus, the capacity of cytokine production was greater in control subjects and in patients with MGUS and MM in response than in symptomatic MM (P=0.005 at 4 h and P=0. 006 at 24 and 48 h for IL-6 and P<0.0001 at 24 h and P<0.001 at 48 h for TNF-alpha). These differences remained significant after adjustment on the basis of the lymphocyte count (P<0.001 for IL-6 and TNF-alpha at 24 and 48 h). The impaired IL-6 and TNF-alpha production in patients with symptomatic MM is probably due to a tumour-related immunosuppressive status.
Department of Clinical Biochemistry (Unit for Cancer Research), Hospital Clínic, Barcelona, Catalonia, Spain. xfilella@medicina.ub.es
X
X
Filella
J
J
Bladé
S
S
Montoto
R
R
Molina
F
F
Coca
E
E
Montserrat
A M
AM
Ballesta
D016022:Case-Control Studies; D006801:Humans; D007108:Immune Tolerance; D066298:In Vitro Techniques; D015850:Interleukin-6 / Q000097:blood*; D018655:Lymphocyte Count; D009101:Multiple Myeloma / Q000097:blood / Q000276:immunology*; D010265:Paraproteinemias / Q000097:blood / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000096:biosynthesis*
D015850:Interleukin-6; D014409:Tumor Necrosis Factor-alpha